IRD – opus genetics, inc. (US:NASDAQ)

News

Opus Genetics Highlights 2025 Progress and Upcoming 2026 Catalysts
Opus Genetics (NASDAQ:IRD) was downgraded by analysts at Wall Street Zen<
The 2 Riskiest Stocks Investors Are Betting On With Over 300% Upside [Yahoo! Finance]
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com